Daniel J. Siegwart
Papers
1
Total Citations
200
H-Index
1
About
Daniel J. Siegwart is a leading figure in biomaterials and nanomedicine, whose work centers on engineering precision delivery systems for therapeutic nucleic acids and proteins. His most impactful contribution is the development of high-throughput combinatorial synthesis platforms for nanoparticles, exemplified by his landmark 2011 study on chemically diverse core-shell nanoparticles for intracellular delivery. In that work, Siegwart and colleagues created 1,536 structurally distinct nanoparticles, systematically varying cationic cores and shells to decode the complex relationships between nanoparticle chemistry, cellular internalization, and delivery efficacy—a feat that revealed design principles inaccessible through traditional low-throughput approaches. With over 200 citations, this paper established a new paradigm for rationally optimizing non-viral delivery vectors. Siegwart’s broader impact includes pioneering lipid-like materials for mRNA delivery, advancing the understanding of endosomal escape, and translating these technologies toward clinical applications. His work has been recognized with numerous awards, including the NIH Director’s New Innovator Award, and continues to shape the design of next-generation therapeutics for gene editing, cancer immunotherapy, and vaccine development.
Research Focus
Key Achievements
Top Papers
- 1